Your browser doesn't support javascript.
Vaccine Administration: The Growing Role of Prefilled Syringes
Pharmaceutical Technology Europe ; 34(8):19-21, 2022.
Article in English | ProQuest Central | ID: covidwho-20242828
ABSTRACT
(Note The MIDAS database reflects vaccine doses that are dispensed with a prescription in retail or hospital settings, so the COVID-19 vaccines and other public-health-administered vaccines are not fully reflected in that data set.) Stamoran adds, "However, across the rest of the world, vial-based vaccines still make up the majority of the volume dispensed." [...]there is plenty of room for growth for this newer administration device. [...]PFS are now widely used for annual flu shots, heparin injections, and a growing list of injectable therapies across multiple disease states. According to a 2021 article authored byGuillaume Lehee, R&D Innovation Leader for BD Medical-Pharmaceutical Systems, the use of PFS to vaccinate 300 million individuals in the United States in the event of a future pandemic could save more than three million hours of healthcare practitioners' time (1). [...]today's PFS are not yet proven to be compatible with ultrafrozen temperatures as the existing glass materials and other components may not stand up to the extremely low required temperatures," explains Stamoran.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Topics: Vaccines Language: English Journal: Pharmaceutical Technology Europe Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Topics: Vaccines Language: English Journal: Pharmaceutical Technology Europe Year: 2022 Document Type: Article